BioMarin Pharmaceuticals BMRN Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's other intangible assets—net?
- BioMarin Pharmaceuticals (BMRN) reported other intangible assets—net of $204.66M in Q1 2026.
- How has BioMarin Pharmaceuticals's other intangible assets—net changed year-over-year?
- BioMarin Pharmaceuticals's other intangible assets—net decreased by 17.3% year-over-year, from $247.35M to $204.66M.
- What is the long-term trend for BioMarin Pharmaceuticals's other intangible assets—net?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's other intangible assets—net has grown at a -12.5% compound annual growth rate (CAGR), from $417.27M to $213.84M.